214 related articles for article (PubMed ID: 23289900)
1. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.
Freitas VM; do Amaral JB; Silva TA; Santos ES; Mangone FR; Pinheiro Jde J; Jaeger RG; Nagai MA; Machado-Santelli GM
Mol Cancer; 2013 Jan; 12():2. PubMed ID: 23289900
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15.
Kelwick R; Wagstaff L; Decock J; Roghi C; Cooley LS; Robinson SD; Arnold H; Gavrilović J; Jaworski DM; Yamamoto K; Nagase H; Seubert B; Krüger A; Edwards DR
Int J Cancer; 2015 Feb; 136(4):E14-26. PubMed ID: 25099234
[TBL] [Abstract][Full Text] [Related]
3. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
[TBL] [Abstract][Full Text] [Related]
4. Progesterone acts via the progesterone receptor to induce adamts proteases in ovarian cancer cells.
Lima MA; da Silva SV; Freitas VM
J Ovarian Res; 2016 Feb; 9():9. PubMed ID: 26916548
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic properties of ADAMTS-4 in vitro.
Hsu YP; Staton CA; Cross N; Buttle DJ
Int J Exp Pathol; 2012 Feb; 93(1):70-7. PubMed ID: 22264287
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells.
Hooshmand S; Ghaderi A; Yusoff K; Karrupiah T; Rosli R; Mojtahedi Z
Cell Adh Migr; 2013; 7(3):297-303. PubMed ID: 23563506
[TBL] [Abstract][Full Text] [Related]
7. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.
Zheng X; Jiang F; Katakowski M; Zhang ZG; Lu QE; Chopp M
Cancer Biol Ther; 2009 Jun; 8(11):1045-54. PubMed ID: 19395875
[TBL] [Abstract][Full Text] [Related]
8. siRNA-knockdown of ADAMTS-13 modulates endothelial cell angiogenesis.
Tang H; Lee M; Kim EH; Bishop D; Rodgers GM
Microvasc Res; 2017 Sep; 113():65-70. PubMed ID: 28546076
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between FAT10 expression and biological behaviors in infitrating ductal carcinoma of breast].
Guo H; Tan P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 39(11):1125-30. PubMed ID: 25432368
[TBL] [Abstract][Full Text] [Related]
10. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.
Chung YR; Kim H; Park SY; Park IA; Jang JJ; Choe JY; Jung YY; Im SA; Moon HG; Lee KH; Suh KJ; Kim TY; Noh DY; Han W; Ryu HS
Hum Pathol; 2015 Jul; 46(7):1027-35. PubMed ID: 26004371
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS-1 Is Found in the Nuclei of Normal and Tumoral Breast Cells.
Silva SV; Lima MA; Cella N; Jaeger RG; Freitas VM
PLoS One; 2016; 11(10):e0165061. PubMed ID: 27764205
[TBL] [Abstract][Full Text] [Related]
12. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
[TBL] [Abstract][Full Text] [Related]
13. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
14. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
[TBL] [Abstract][Full Text] [Related]
15. PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.
Keightley MC; Sales KJ; Jabbour HN
BMC Cancer; 2010 Sep; 10():488. PubMed ID: 20840749
[TBL] [Abstract][Full Text] [Related]
16. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
[TBL] [Abstract][Full Text] [Related]
17. miR‑365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in breast cancer.
Li M; Liu L; Zang W; Wang Y; Du Y; Chen X; Li P; Li J; Zhao G
Int J Oncol; 2015 Jul; 47(1):296-302. PubMed ID: 25998153
[TBL] [Abstract][Full Text] [Related]
18. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
[TBL] [Abstract][Full Text] [Related]
19. LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.
Piccolo E; Tinari N; Semeraro D; Traini S; Fichera I; Cumashi A; La Sorda R; Spinella F; Bagnato A; Lattanzio R; D'Egidio M; Di Risio A; Stampolidis P; Piantelli M; Natoli C; Ullrich A; Iacobelli S
J Mol Med (Berl); 2013 Jan; 91(1):83-94. PubMed ID: 22864925
[TBL] [Abstract][Full Text] [Related]
20. STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
Xie J; Yang Y; Sun J; Jiao Z; Zhang H; Chen J
Clin Breast Cancer; 2019 Feb; 19(1):e195-e207. PubMed ID: 30253922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
